cosmin4000 / iStockphoto.com
The US Patent and Trademark Office (USPTO) has issued a new CRISPR/Cas9 patent to the University of California (UC), the University of Vienna and microbiologist Emmanuelle Charpentier.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Emmanuelle Charpentier, University of Vienna, University of California, CRISPR/Cas9, gene editing